Related references
Note: Only part of the references are listed.History of ectonucleotidases and their role in purinergic signaling
Herbert Zimmermann
BIOCHEMICAL PHARMACOLOGY (2021)
Structure-Activity Relationship of Heterocyclic P2Y14 Receptor Antagonists: Removal of the Zwitterionic Character with Piperidine Bioisosteres
Young-Hwan Jung et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Update of P2Y Receptor Pharmacology: IUPHAR Review:27
Kenneth A. Jacobson et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
2-Substituted α,β-Methylene-ADP Derivatives: Potent Competitive Ecto-5'-nucleotidase (CD73) Inhibitors with Variable Binding Modes
Sanjay Bhattarai et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
P2Y1-like nucleotide receptors-Structures, molecular modeling, mutagenesis, and oligomerization
Alexander Neumann et al.
WILEY INTERDISCIPLINARY REVIEWS-COMPUTATIONAL MOLECULAR SCIENCE (2020)
Modulation of P2Y6R expression exacerbates pressure overload-induced cardiac remodeling in mice
Kakeru Shimoda et al.
SCIENTIFIC REPORTS (2020)
Lack of adipocyte purinergic P2Y6 receptor greatly improves whole body glucose homeostasis
Shanu Jain et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Structure-Activity Relationship of Purine and Pyrimidine Nucleotides as Ecto-5′-Nucleotidase (CD73) Inhibitors
Anna Junker et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Exacerbated intestinal inflammation in P2Y6 deficient mice is associated with Th17 activation
Mabrouka Salem et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2019)
P2Y6 and P2X7 Receptor Antagonism Exerts Neuroprotective/ Neuroregenerative Effects in an Animal Model of Parkinson's Disease
Agatha Oliveira-Giacomelli et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2019)
GPCRs show widespread differential mRNA expression and frequent mutation and copy number variation in solid tumors
Krishna Sriram et al.
PLOS BIOLOGY (2019)
The G protein-coupled P2Y6 receptor promotes colorectal cancer tumorigenesis by inhibiting apoptosis
Morgane Placet et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2018)
A promising drug candidate for the treatment of glaucoma based on a P2Y6-receptor agonist
Tali Fishman Jacob et al.
PURINERGIC SIGNALLING (2018)
The metabolism of ecto-5′-nucleotidase (CD73) inhibitor-α,β-methylene adenosine diphosphate in BALB/c mice
Marta Tomczyk et al.
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS (2018)
A purinergic P2Y6 receptor agonist prodrug modulates airway inflammation, remodeling, and hyperreactivity in a mouse model of asthma
Anne Chetty et al.
JOURNAL OF ASTHMA AND ALLERGY (2018)
Purinergic P2Y receptors: Molecular diversity and implications for treatment of cardiovascular diseases
Akiyuki Nishimura et al.
PHARMACOLOGY & THERAPEUTICS (2017)
Pyrimidine nucleotides containing a (S)-methanocarba ring as P2Y6 receptor agonists
Kiran S. Toti et al.
MEDCHEMCOMM (2017)
Anti-proliferative Effects of Nucleotides on Gastric Cancer via a Novel P2Y6/SOCE/Ca2+/β-catenin Pathway
Hanxing Wan et al.
SCIENTIFIC REPORTS (2017)
Application of the Pentafluorosulfanyl Group as a Bioisosteric Replacement
Munia F. Sowaileh et al.
CHEMMEDCHEM (2017)
Structure-Based Design of 3-(4-Aryl-1H-1,2,3-triazol-1-yl)-Biphenyl Derivatives as P2Y14 Receptor Antagonists
Anna Junker et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Purinergic P2Y6 receptors heterodimerize with angiotensin AT1 receptors to promote angiotensin II-induced hypertension
Akiyuki Nishimura et al.
SCIENCE SIGNALING (2016)
Purinergic P2Y6 receptors heterodimerize with angiotensin AT1 receptors to promote angiotensin II-induced hypertension
Akiyuki Nishimura et al.
SCIENCE SIGNALING (2016)
Molecular modeling of the human P2Y14 receptor: A template for structure-based design of selective agonist ligands
Kevin Trujillo et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
The Absence of Purinergic G Protein-Coupled Receptor 6 on Dendritic Cells Amplifies Antigen-Induced Pulmonary Inflammation
Laura B. Fanning et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)
UDP-Sugars as Extracellular Signaling Molecules: Cellular and Physiologic Consequences of P2Y14 Receptor Activation
Eduardo R. Lazarowski et al.
MOLECULAR PHARMACOLOGY (2015)
A new, sensitive ecto-5′-nucleotidase assay for compound screening
Marianne Freundlieb et al.
ANALYTICAL BIOCHEMISTRY (2014)
Inhibition of UDP/P2Y6 Purinergic Signaling Prevents Phagocytosis of Viable Neurons by Activated Microglia In Vitro and In Vivo
Jonas J. Neher et al.
GLIA (2014)
RAPID SYNTHESIS OF ALKOXYAMINE HYDROCHLORIDE DERIVATIVES FROM ALKYL BROMIDE AND N,N'-DI-TERT-BUTOXYCARBONYLHYDROXYLAMINE [(Boc)2NOH]
P. Suresh Jayasekara et al.
SYNTHETIC COMMUNICATIONS (2014)
4-Alkyloxyimino-cytosine nucleotides: tethering approaches to molecular probes for the P2Y6 receptor
P. Suresh Jayasekara et al.
MEDCHEMCOMM (2013)
Automated design of ligands to polypharmacological profiles
Jeremy Besnard et al.
NATURE (2012)
Pyrimidine Nucleotides with 4-Alkyloxyimino and Terminal Tetraphosphate δ-Ester Modifications as Selective Agonists of the P2Y4 Receptor
Hiroshi Maruoka et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Signalling and pharmacological properties of the P2Y14 receptor
T. K. Harden et al.
ACTA PHYSIOLOGICA (2010)
Human P2Y14 Receptor Agonists: Truncation of the Hexose Moiety of Uridine-5′-Diphosphoglucose and Its Replacement with Alkyl and Aryl Groups
Arijit Das et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
5-OMe-UDP is a Potent and Selective P2Y6-Receptor Agonist
Tamar Ginsburg-Shmuel et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Pyrimidine Ribonucleotides with Enhanced Selectivity as P2Y6 Receptor Agonists: Novel 4-Alkyloxyimino, (S)-Methanocarba, and 5′-Triphosphate γ-Ester Modifications
Hiroshi Maruoka et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Synthesis and potency of novel uracil nucleotides and derivatives as P2Y2 and P2Y6 receptor agonists
Hyojin Ko et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2008)
From ATP to AZD6140:: The discovery of an orally active reversible P2Y12 receptor antagonist for the prevention of thrombosis
Brian Springthorpe et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Structure-activity relationship of uridine 5'-diphosphoglucose analogues as agonists of the human P2Y14 receptor
Hyojin Ko et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Synthesis and structure-activity relationships of uracil nucleotide derivatives and analogues as agonists at human P2Y2, P2Y4, and P2Y6 receptors
Ali El-Tayeb et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Positive inotropic effects by uridine triphosphate (UTP) and uridine diphosphate (UDP) via P2Y2 and P2Y6 receptors on cardiomyocytes and release of UTP in man during myocardial infarction
AK Wihlborg et al.
CIRCULATION RESEARCH (2006)
A direct method for the synthesis of nucleoside 5'-methylenebis(phosphonate)s from nucleosides
M Kalek et al.
TETRAHEDRON LETTERS (2005)
Share Paper
